Our Expansive Clinical Trials Program

Clinical trials provide patients with the earliest access to the newest and most promising cancer therapies.

John Theurer Cancer Center has more than 350 ongoing clinical trials conducted independently and in partnership with research and pharmaceutical companies, research consortiums, patient advocacy groups, and the National Institutes of Health. Participating in a clinical trial can allow you to be among the first in the world to access potentially lifesaving therapies. Please check our clinical trials database regularly, as the information is frequently updated. You can also CALL 551-996-5834  for more information.

View our Current Clinical Trials

Awards and Accreditation

Hackensack University Medical Center is continuing to prove that “impossible” is just an opinion. We’ve created an environment that encourages medical innovation to flourish by recruiting top doctors and giving them freedom to push research and treatments beyond traditional thinking. We’re proud to highlight a few of the awards Hackensack University Medical Center has earned.

Dr. Noa Biran Discusses Multiple Myeloma Clinical Trials

Hear how we are using the patient’s immune system to change the natural history of high-risk myeloma and increase the survival rate from Dr. Noa Biran.

Is a Clinical Trial Right for You?

Clinical trials are essential for progress to be made against cancer. Phase I studies are the first step, assessing the best dose of a new drug or treatment combination in a small group of patients. Phase II studies evaluate safety and effectiveness of the new treatment in more patients. Phase III studies compare the safety and effectiveness of the new treatment to a placebo (inactive therapy) or to a standard therapy already in use. At John Theurer Cancer Center, we offer all phases of clinical trials, with a particularly robust roster of Phase I/Ib studies—offering earlier access to new options to patients.

Participants in clinical trials can play a more active role in their own health care, gain access to new research treatments before they are widely available, and help others by contributing to medical research. When you participate in a clinical trial, you not only have access to a treatment that offers hope for you, but you also help define the future of cancer care for other patients. Your participation is entirely voluntary, and our research team will help you understand all aspects of your care

We’ve prepared these frequently asked questions to help you better understand cancer clinical trials and to help you decide if a clinical trial is right for you.

What is standard therapy?

Standard therapy is the scientifically established course of treatment for a particular disease. Because advances in medical science are constantly expanding the choice of available drugs and the consensus on how to best treat and monitor a particular type of cancer, standard therapy is constantly evolving. In some cases, there is no consensus standard therapy that is effective. This means that more research must be done to discover a treatment that works, or to prove scientifically in a clinical trial which existing treatment options are best. The clinical trials of today define the standard therapies of tomorrow.

What is an investigational therapy?

Investigational therapies include drugs not yet approved by the U.S. Food and Drug Administration, drugs approved for some cancers that are being assessed for treating different cancers, and combinations of approved drugs that have never been used together before. Your treatment team will explain which therapies being assessed in a clinical trial are investigational and which are standard therapies.

When might a clinical trial be appropriate for me?

Your doctor may recommend that you participate in a clinical trial if he or she feels that you may respond better to a new treatment than to the available standard therapy for your disease. If a study drug proves to be effective, participating in a clinical trial can allow you to be among the first patients in the world to access a potentially lifesaving therapy. Other clinical trials assess new ways to screen for or prevent cancer, or to evaluate the effect of a therapy on patients’ quality of life.

How do I know if I can participate?

All clinical trials have guidelines called “inclusion criteria” which explain who can participate. These criteria include, for example, the type and stage of disease you need to have to be in the study, information about prior treatments, your overall state of health, and your age, among other factors. Your care team can help you identify clinical trials for which you may be eligible, how long you may be in the study, and what to expect during your experience on the study so you can make an informed decision about participating. Your decision to enroll is entirely yours, and you can withdraw at any time if you change your mind.

Our Clinical Trials

Dr. Joshua Richter Discusses Multiple Myeloma Clinical Trials

Dr. Richter discusses the variety of multiple myeloma clinical trials that are conducted at John Theurer Cancer Center.